Assay development/ Screening
Our Services
-
Tailored assay development focused on specific biological targets, disease pathways, or cellular phenotypes.
Expertise across biochemical and cellular assays.
Designed to support screening campaigns across a broad range of therapeutic modalities, including small molecules, biologics, nucleic acid based agents and emerging drug classes.
-
Automated liquid handling systems to enable high throughput dispensing and flexible automation workflows, ideal for screening applications across diverse assay formats
Miniaturised and scalable formats (96-, 384-, 1536-well) to enable cost-efficient hit discovery.
-
Broad portfolio of functional cellular assays including cell proliferation, viability, reporter gene expression, and cytokine profiling.
Biochemical formats include enzyme activity, protein-protein interactions, and receptor-ligand binding.
Customisable systems for disease-relevant models including oncology, inflammation, neurodegeneration, and infectious disease.
-
Expertise in precise genome modification using CRISPR/Cas9 and related systems, enabling targeted knockouts, knock-ins, and site-specific point mutations.
Custom-engineered cell lines, organoids, or model systems tailored to reflect disease-relevant genotypes, resistance mechanisms, or therapeutic targets.
Capabilities
With expertise in assay design, optimisation, and validation, our team supports drug discovery, diagnostics, and biomarker development through precise, scalable, and reliable testing solutions.
FMI Capabilities
Custom assay design tailored to biological targets or pathways
High-throughput screening using automated platforms
Cell-based and biochemical assays for functional and mechanistic studies
Assay validation and quality control in line with industry standards
Data analysis and hit triage for lead identification and profiling
Team
Dr Kienan Savage
Academic Lead
DNA damage/response repair mechanisms
Dr Claudia Hamilton
Research Fellow
Cell death pathways/ small molecule screening
Dr. Catherine Higgins
Senior Research Fellow
Cell death pathways/ small molecule screening
Dr Sarah McFetridge
Research Fellow
Bacteriology/ Immunology
Dr Andrew Shaw
Research Fellow
Metabolism/ Epigenetics
Our technology